CXCL9 and CXCL10 play an important role in regulating NK cell and T lymphocyte influx to the site of infection and for control of vaginal HSV infection [6]; therefore, modulated production of specific chemokines may be imperative for future vaccine adjuvant candidates [37]. The gene discussed is CXCL9; the disease is infection.